Cover photo
National Institute of Arthritis and Musculoskeletal and Skin Diseases
285 followers|138,601 views


Although it's primarily a skin disease, the effects of #psoriasis are more than skin deep. It can affect people emotionally and is associated with other diseases. See this NIH Senior Health fact sheet for more:
Add a comment...
In a NIAMS-supported ancillary project of the TEAR trial (Treatment of Early Aggressive Rheumatoid Arthritis), researchers found that patients with early RA who were treated with methotrexate alone, or methotrexate in combination with etanercept or triple therapy, had improved HDL function. Results could lead to targeted therapies to prevent cardiovascular disease in people with RA. Read the PubMed abstract here (with a link to the publicly accessible full article):
Add a comment...
NIAMS Spanish portal featured in e-poster @HCMMconf#hcmmconf16
Add a comment...
Tiahna Spencer, 2016 NIAMS Summer Intern, reflects on her research experience in the Systemic Autoimmunity Branch.
Add a comment...
Today 3:30 – 5 p.m. EDT: The NIAMS will hold a pre-application webinar for the re-issued Funding Opportunity Announcement (FOA) RFA-AR-17-001, Centers of Research Translation (P50). The intent of the webinar is to provide an overview of the FOA and to address questions pertinent to preparing applications. The webinars are optional and not required for application submission. For more info and to register for the webinar:
Add a comment...
Kristin (on left in the photo, with NHLBI’s Dr. Nehal Mehta) lives with #psoriasis and joined an NIH clinical study. Read about her experience in MedlinePlus Magazine:
Add a comment...
NIAMS’ Alasdair Steven demonstrates the potential for bubblegram imaging in mapping components of viruses and cellular structures:
Add a comment...
Did you know? There are a number of different kinds of treatments for #psoriasis. Your doctor can help you decide which ones are best for you.
Add a comment...
Two NIAMS-supported studies have yielded new insights about the process of excess bone formation in fibrodysplasia ossificans progressiva (FOP). These discoveries may lead to potential drug treatments. The image shows a skeleton of a man affected by FOP. Read the Spotlight on Research story here:
Add a comment...
Contact Information
Contact info
(877) 22-NIAMS
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Information Clearinghouse National Institutes of Health 1 AMS Circle Bethesda, MD 20892-3675
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the U.S. Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. 

NIAMS Google Plus (G+) Policies

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) participates in this open forum to increase government transparency, enhance information sharing, promote public participation, and encourage collaboration with the U.S. Department of Health and Human Services (HHS), the National Institutes of Health, and the NIAMS.

The NIAMS reserves the right to monitor all postings to its G+ page. Where commenting is supported on this or any other websites owned or administered by the NIAMS, we encourage you to share your thoughts as they relate to the topic being discussed. We reserve the right to remove comments that are inconsistent with our policy, at our discretion.

We will consider your comments when posting new updates, but we are unable to respond directly to individual inquiries. We are also unable to answer questions about your specific health care situation.

The views expressed in comments reflect those of the author and do not necessarily reflect the official views of the NIAMS, the National Institutes of Health (NIH), the U.S. Department of Health and Human Services, or the Federal Government.

Comments that contain the following will be deleted:

  • Political endorsements of parties, candidates, or groups
  • Commercial endorsements of products, services, organizations, or other entities
  • Content that infringes on copyrights
  • Comments on any ongoing investigation of any sort
  • Discriminatory, racist, abusive, obscene, inflammatory, unlawful, or otherwise objectionable statements, language, or content
  • Solicitations of funds
  • Procurement-sensitive information related to any current/future NIAMS acquisitions

We welcome your comments at any time. However, given the need to manage Government resources responsibly, we will review comments during regular business hours, Monday through Friday. Comments submitted on weekends or holidays will be reviewed on the next business day.

Reporters are asked to send questions to the NIAMS Office of Science Policy, Planning and Communications (OSPPC) rather than submitting questions here as comments. Contact the OSPPC at 301-496-8190 or by email to

We reserve the right to block or delete offenders of this policy. We will keep records of all comments that are deleted for the above reasons, as well as those that are posted.


Your Privacy

Remember that your posts are public. When posting, please do not include information (e.g., social security numbers) in the text of your comment that personally identifies you in a way you do not intend. Additional guidance as to how the NIAMS regards privacy issues can be found in our Privacy Statement at

Visitors who become fans or friends of this page, or otherwise use or interact with the site, agree to adhere to the Google+ Policies and  Principles (

Please consider carefully what you choose to post about yourself. You participate at your own risk, taking personal responsibility for your comments. A link to Google’s privacy policy is available at

Linking and Disclaimer of Endorsement

The appearance of external links on this site does not constitute endorsement by the NIAMS, the NIH, or the U.S. Department of Health and Human Services, nor do we endorse the views, products and services they may offer.

We do not guarantee the accuracy, relevance, timeliness, or completeness of information contained on non-NIAMS websites.

We do not guarantee that outside sites comply with Section 508 (Accessibility Requirements) of the Rehabilitation Act.

When you select a link to an outside site, you are leaving this page and are subject to the privacy and security policies of that site.